Categories

August 2022

Feature Articles on the Act for the Development of Biotech and Pharmaceutical Industry of Taiwan (VI) –The MOEA of Taiwan Pre-announced Draft Sub-law: Regulations Governing Management of Research Personnel’s Concurrent Holding of Jobs and Investments by Contribution of Technology to Start-up Biotech and Pharmaceutical Company

August 2022

Feature Articles on the Act for the Development of Biotech and Pharmaceutical Industry of Taiwan (V) –The Draft Regulations Announced by the MOEA and MOF of Taiwan: Regulations Governing the Tax Deferral for a Top Executive or Technology Investor in Biotech and Pharmaceutical Companies, Regulations Governing Biotech and Pharmaceutical Companies' Issuance of Stock Options, and Regulations Governing Application of Deferred Taxation of Income Tax in Accordance with the Act for the Development of Biotech and Pharmaceutical Industry

August 2022

Analysis of the 2022 Amendment to the Anti-Monopoly Law of the Mainland China

July 2022

Feature Articles on the Act for the Development of Biotech and Pharmaceutical Industry of Taiwan (IV) –The MOEA of Taiwan Announced the Regulatory Highlights of the Drafts Concerning the Tax Credits for the Income from Investment in Biological or Pharmaceutical Companies by Profit-seeking Enterprises or Individuals

July 2022

Construction Extension of Time and the Change of Critical Path (Taiwan)

July 2022

Focus on the Choice of Governing Law in Cross-Border Transactions (Mainland China)